Oral bisphosphonate use associated with a decreased risk of breast cancer.
John Henry
JH
Dreyfuss
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D012306:Risk; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates